Dice CEO: Energy, T...
Health Care: Drugs
DUSA Pharmaceuticals Inc. (DUSA: NASDAQ)
$4.91 -0.25 | -4.84%
06/01/12 - 04:00 PM ET
Company Income Statement
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Sales | 45.30M | 37.43M | 29.81M | 29.54M |
| Cost of Sales | 6.48M | 6.88M | 6.17M | 6.67M |
| Gross Operating Profit | 38.82M | 30.56M | 23.64M | 22.88M |
| Selling, General, and Administrative Expenses | 25.34M | 22.36M | 21.17M | 22.30M |
| Research & Development | 5.28M | 4.93M | 4.31M | 6.64M |
| Operating Income before D & A (EBITDA) | 8.21M | 3.26M | -1.85M | -6.07M |
| Depreciation & Amortization | 445.23K | 396.00K | 501.67K | 455.00K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income - Net | -966.76K | -164.59K | -85.77K | 1.77M |
| Special Income / Charges | 0.00 | 0.00 | -75.00K | -1.50M |
| Total Income Before Interest Expenses (EBIT) | 6.79M | 2.70M | -2.51M | -6.25M |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 |
| Pre-Tax Income | 6.79M | 2.70M | -2.51M | -6.25M |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | 6.79M | 2.70M | -2.51M | -6.25M |
| Net Income From Discontinued Operations | 526.54K | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | 7.32M | 2.70M | -2.51M | -6.25M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | 7.32M | 2.70M | -2.51M | -6.25M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
6.79M | 2.70M | -2.43M | -4.75M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | 6.79M | 2.70M | -2.51M | -6.25M |
| Basic EPS from Continuing Ops. | 0.28 | 0.11 | -0.10 | -0.26 |
| Basic EPS from Discontinued Ops. | 0.02 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | 0.30 | 0.11 | -0.10 | -0.26 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | 0.30 | 0.11 | -0.10 | -0.26 |
| Basic Normalized Net Income/Share | 0.28 | 0.11 | -0.10 | -0.20 |
| EPS fr Continuing Ops. | 0.26 | 0.11 | -0.10 | -0.26 |
| EPS fr Discontinued Ops | 0.02 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | 0.28 | 0.11 | -0.10 | -0.26 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | 0.28 | 0.11 | -0.10 | -0.26 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
0.26 | 0.11 | -0.10 | -0.20 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with DUSA
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorTop-Rated Biotechnology Stocks
- UserThatBobGuy Portfolio 1
- ContributorBarron's Insider Purchases ...
- ContributorTop 10 Insider Purchases: J...
- Userjoshuparks Portfolio 1
- Uservladys buttom fishing
- Userbill 3
- UserHeld's
Latest DUSA Headlines from TheStreet
- 8 Stocks Under $10 Ripping Higher 05.03.12 | 01:05 pm
- DUSA Pharmaceuticals Inc. Stock Upgraded (DUSA) 11.14.11 | 06:11 am
- DUSA Pharmaceuticals Inc. Stock Downgraded (DUSA) 07.28.11 | 07:07 am
- DUSA Stock Hits New 52-Week High (DUSA) 05.25.11 | 10:05 am
- DUSA Stock Soars (DUSA) 05.05.11 | 10:05 am
- DUSA Pharmaceuticals Inc. Stock Upgraded (DUSA) 03.04.11 | 05:03 pm
- DUSA Stock Soars Higher (DUSA) 03.03.11 | 10:03 am
- Cautious Bull
03.08.10 | 11:03 am - The Pisani Paradox 09.28.09 | 11:09 am
- Wednesday's Health Winners & Losers 10.03.07 | 03:10 pm
Press Releases for DUSA
- DUSA Pharmaceuticals, Inc.® To Host First Quarter 2011 Corporate Highlights And Financial Results Webcast And Conference Call - Business Wire 04.28.11 | 08:04 am
- A Patient Receiving Levulan Photodynamic Therapy. (Photo: Business Wire) - Business Wire 03.03.11 | 06:03 am
- DUSA Pharmaceuticals, Inc.® To Host Fourth Quarter And Full Year 2010 Corporate Highlights And Financial Results Conference Call - Business Wire 02.25.11 | 06:02 am
- DUSA Pharmaceuticals To Present At The 4th Annual Maxim Group Growth Conference - PR Newswire 11.11.10 | 08:11 am
- DUSA Pharmaceuticals Named To Deloitte's 2010 Technology Fast 500 List Of Fastest Growing Companies In North America - PR Newswire 10.26.10 | 03:10 pm
- DUSA Pharmaceuticals To Present At The Rodman & Renshaw 12th Annual Healthcare Conference - PR Newswire 09.07.10 | 08:09 am
- DUSA Pharmaceuticals Receives Response From FDA On Orphan Drug Designation Status - PR Newswire 08.06.10 | 12:08 pm
- DUSA Pharmaceuticals Reports U.S. Patent Office Upholds Key Photodynamic Therapy Patent - PR Newswire 06.24.10 | 06:06 am
- DUSA Pharmaceuticals Announces Slate Of Nominees For Election To The Board Of Directors - PR Newswire 05.13.10 | 12:05 pm
- DUSA Pharmaceuticals Reports Notice Of Allowance For Key PDT Device Patent - PR Newswire 05.07.10 | 06:05 am
Partner Headlines for DUSA
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 03.30.12 | 09:03 am
- DUSA Pharmaceuticals Is A Small Gem - Seeking Alpha 12.23.11 | 02:12 pm
- 20 Smart Money Stock Picks Trading Under $5 - Seeking Alpha 11.03.11 | 07:11 am
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 07.01.11 | 09:07 am
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 03.07.11 | 09:03 am
- Morning Market Movers (GTEC, ASGR, LSBK, DUSA) - Benzinga 03.03.11 | 09:03 am
- UPDATE 1-DUSA to end skin drug deal with Stiefel Laboratories - Reuters 10.06.10 | 08:10 am
- UPDATE 1-DUSA to stop cancer trial as FDA denies orphan status - Reuters 08.06.10 | 02:08 pm
